References
Dawoud, C., Widmann, K. M., Czipin, S., Pramhas, M., Scharitzer, M, Stift, A. et al. Efficacy of cx601 (darvadstrocel) for the treatment of perianal fistulizing Crohn’s disease—A prospective nationwide multicenter cohort study. Wien Klin Wochenschr. Published online October 12, 2023.
Bor R, Farkas K, Bálint A, Szűcs M, Abrahám S, Baradnay G, et al. A tumornekrózis-faktor-alfa-gátlók hatékonysága perianalis fisztulázó Crohn-betegségben [Efficacy of tumor necrosis factor-alpha inhibitors in fistulising perianal Crohn’s disease. orv Hetil. 2013;154(49:1943–8.
Sakha YA, Ehsani E, Roshandel E, Jalili A, Vahdani N, Hajifathali A. Assessment of the Effect of Infliximab on Immunomodulation Properties of Mesenchymal Stem Cells In Vitro. Adv Pharm Bull. 2021;11(4):739–45.
Duijvestein M, Molendijk I, Roelofs H, Vos AC, Verhaar AP, Reinders ME, et al. Mesenchymal stromal cell function is not affected by drugs used in the treatment of inflammatory bowel disease. Cytotherapy. 2011;13(9):1066–73.
Huang HR, Zan H, Lin Y, Zhong YQ. Effects of azathioprine and infliximab on mesenchymal stem cells derived from the bone marrow of rats in vitro. Mol Med Rep. 2014;9(3):1005–12.
Tozer PJ, Burling D, Gupta A, Phillips RK, Hart AL. Review article: medical, surgical and radiological management of perianal Crohn’s fistulas. Aliment Pharmacol Ther. 2011;33(1):5–22.
Beets-Tan RG, Beets GL, van der Hoop AG, Kessels AG, Vliegen RF, Baeten CG, et al. Preoperative MR imaging of anal fistulas: Does it really help the surgeon? Radiology. 2001;218(1):75–84.
Acknowledgements
We appreciate the contributions of all the doctors, coworkers, and friends involved in this study.
Author information
Authors and Affiliations
Contributions
Both authors contributed to the conceptualization and writing of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
M.-L. Ye and F. Cheng declare that they have no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ye, ML., Cheng, F. Comments on: “Efficacy of cx601 (darvadstrocel) for the treatment of perianal fistulizing Crohn’s disease—A prospective nationwide multicenter cohort study”. Wien Klin Wochenschr (2024). https://doi.org/10.1007/s00508-024-02359-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00508-024-02359-9